Introduction: Tirzepatide peptides offer a dual GIP and GLP-one receptor agonist motion having a 5-working day 50 %-existence enabling once-weekly dosing and outstanding fat loss efficacy in scientific trials. In many fat loss journeys, challenges often compound: finding a good treatment method with workable dosing frequency, making sure accessibi